PHARMACIES COLSON: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
PHARMACIES COLSON
Largest movements
- Financial fixed assets +€72,945
new in 2025: €72,945
- Cash -€53,856
down €53,856 (-23.0%), from €233,920 to €180,064
mainly Other debts (-€102,453) and Investment in fixed assets (net) (-€84,320)
- Stocks and contracts +€48,555
up €48,555 (+26.1%), from €186,069 to €234,623
- Current investments -€25,000
no longer reported in 2025 (was €25,000)
- Receivables within one year +€24,636
up €24,636 (+15.3%), from €161,539 to €186,175
of which Trade receivables: +€21,565
- Reserves +€277,000
up €277,000 (+4,432%), from €6,250 to €283,250
- Profit (loss) carried forward -€276,869
down €276,869 (-99.7%), from €277,634 to €766
- Other debts -€102,453
down €102,453 (-69.5%), from €147,453 to €45,000
- Trade debts +€79,881
up €79,881 (+83.5%), from €95,665 to €175,546
- Debts after one year +€51,000
new in 2025: €51,000
- Gross operating margin -€151,651
down €151,651 (-29.8%), from €509,481 to €357,830
- Taxes -€47,448
down €47,448 (-82.7%), from €57,363 to €9,915
- Staff costs +€16,046
up €16,046 (+5.8%), from €274,776 to €290,821
- Financial income -€10,539
down €10,539 (-86.0%), from €12,253 to €1,713
- Financial charges -€7,373
down €7,373 (-59.7%), from €12,354 to €4,981
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €646,451 | €713,428 | +€66,976 | +10.4% |
| Fixed assets | 21/28 | €28,450 | €108,044 | +€79,594 | +280% |
| Tangible fixed assets | 22/27 | €28,450 | €35,098 | +€6,649 | +23.4% |
| Land and buildings | 22 | €13,770 | €13,770 | = | 0.0% |
| Plant, machinery and equipment | 23 | €11,264 | €9,591 | -€1,673 | -14.9% |
| Furniture and vehicles | 24 | €2,527 | €11,518 | +€8,992 | +356% |
| Other tangible fixed assets | 26 | €888 | €219 | -€669 | -75.3% |
| Financial fixed assets | 28 | - | €72,945 | +€72,945 | |
| Current assets | 29/58 | €618,002 | €605,384 | -€12,618 | -2.0% |
| Stocks and contracts in progress | 3 | €186,069 | €234,623 | +€48,555 | +26.1% |
| Stocks | 30/36 | €186,069 | €234,623 | +€48,555 | +26.1% |
| Amounts receivable within one year | 40/41 | €161,539 | €186,175 | +€24,636 | +15.3% |
| Trade receivables | 40 | €156,393 | €177,958 | +€21,565 | +13.8% |
| Other amounts receivable | 41 | €5,146 | €8,217 | +€3,072 | +59.7% |
| Current investments | 50/53 | €25,000 | - | -€25,000 | |
| Cash at bank and in hand | 54/58 | €233,920 | €180,064 | -€53,856 | -23.0% |
| Deferred charges and accrued income | 490/1 | €11,474 | €4,522 | -€6,953 | -60.6% |
| Total equity and liabilities | 10/49 | €646,451 | €713,428 | +€66,976 | +10.4% |
| Equity | 10/15 | €346,384 | €346,516 | +€131 | 0.0% |
| Contributions | 10/11 | €62,500 | €62,500 | = | 0.0% |
| Reserves | 13 | €6,250 | €283,250 | +€277,000 | +4,432% |
| Distributable reserves | 133 | €6,250 | €283,250 | +€277,000 | +4,432% |
| Profit (loss) carried forward | 14 | €277,634 | €766 | -€276,869 | -99.7% |
| Amounts payable | 17/49 | €300,067 | €366,912 | +€66,845 | +22.3% |
| Amounts payable after more than one year | 17 | - | €51,000 | +€51,000 | |
| Financial debts | 170/4 | - | €51,000 | +€51,000 | |
| Amounts payable within one year | 42/48 | €288,107 | €315,733 | +€27,626 | +9.6% |
| Current portion of amounts payable after more than one year | 42 | - | €51,000 | +€51,000 | |
| Trade debts | 44 | €95,665 | €175,546 | +€79,881 | +83.5% |
| Suppliers | 440/4 | €95,665 | €175,546 | +€79,881 | +83.5% |
| Taxes, remuneration and social security | 45 | €44,989 | €44,188 | -€802 | -1.8% |
| Taxes | 450/3 | €575 | €483 | -€92 | -16.0% |
| Remuneration and social security | 454/9 | €44,414 | €43,705 | -€710 | -1.6% |
| Other amounts payable | 47/48 | €147,453 | €45,000 | -€102,453 | -69.5% |
| Accrued charges and deferred income | 492/3 | €11,960 | €179 | -€11,781 | -98.5% |
| Non-recurring operating income | 76A | - | €1,868 | +€1,868 | |
| Remuneration, social security and pensions | 62 | €274,776 | €290,821 | +€16,046 | +5.8% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €5,181 | €4,726 | -€455 | -8.8% |
| Other operating charges | 640/8 | €4,806 | €3,969 | -€837 | -17.4% |
| Non-recurring operating charges | 66A | €160 | - | -€160 | |
| Gross operating margin | 9900 | €509,481 | €357,830 | -€151,651 | -29.8% |
| Operating profit (loss) | 9901 | €224,558 | €58,313 | -€166,244 | -74.0% |
| Financial income | 75/76B | €12,253 | €1,713 | -€10,539 | -86.0% |
| Recurring financial income | 75 | €12,253 | €1,713 | -€10,539 | -86.0% |
| Financial charges | 65/66B | €12,354 | €4,981 | -€7,373 | -59.7% |
| Recurring financial charges | 65 | €12,354 | €4,981 | -€7,373 | -59.7% |
| Profit (loss) for the period before taxes | 9903 | €224,457 | €55,046 | -€169,411 | -75.5% |
| Income taxes | 67/77 | €57,363 | €9,915 | -€47,448 | -82.7% |
| Profit (loss) for the period | 9904 | €167,094 | €45,131 | -€121,963 | -73.0% |
| Profit (loss) for the period to be appropriated | 9905 | €167,094 | €45,131 | -€121,963 | -73.0% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 19 October 2026 via checked.be.